Commission Regulation (EC) No 1286/2000 of 19 June 2000 amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance)
Date: 2000-06-19
Institutions: European Commission
Subjects: animal product, food inspection, foodstuff, foodstuffs legislation, veterinary drug, waste

20.6.2000

EN

Official Journal of the European Communities

L 145/15

COMMISSION REGULATION (EC) No 1286/2000

of 19 June 2000

amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community
procedure for the establishment of maximum residue limits of veterinary medicinal products in
foodstuffs of animal origin

(Text with EEA relevance)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European
Community,

Having regard to Council Regulation (EEC) No 2377/90 of 26
June 1990 laying down a Community procedure for the estab-
lishment of maximum residue limits of veterinary medicinal
products in foodstuffs of animal origin (1), as last amended by
Commission Regulation (EC) No 2758/1999 (2), and in partic-
ular Articles 6, 7 and 8 thereof,

Whereas:

(1)

(2)

(3)

(4)

In accordance with Regulation (EEC) No 2377/90,
maximum residue limits must be established progres-
sively for all pharmacologically active substances which
are used within the Community in veterinary medicinal
products intended for administration to food-producing
animals.

Maximum residue limits should be established only after
the examination within the Committee for Veterinary
information
Medicinal Products of all
the substance
concerning the safety of
concerned for the consumer of
foodstuffs of animal
origin and the impact of residues on the industrial
processing of foodstuffs.

the relevant
residues of

In establishing maximum residue limits for residues of
veterinary medicinal products in foodstuffs of animal
origin, it is necessary to specify the animal species in
which residues may be present, the levels which may be
present in each of the relevant meat tissues obtained
from the treated animal (target tissue) and the nature of
the residue which is relevant
for the monitoring of
residues (marker residue).

For the control of residues, as provided for in appro-
priate Community legislation, maximum residue limits
should usually be established for the target tissues of
liver or kidney. However,
the liver and kidney are
frequently removed from carcases moving in inter-
national
trade, and maximum residue limits should
therefore also always be established for muscle or fat
tissues.

(6)

(7)

(8)

(9)

maximum residue limits must also be established for
eggs, milk or honey.

Phenoxymethylpenicillin should be inserted into Annex I
to Regulation (EEC) No 2377/90.

Calcium aspartate, rhei radix, standardised extracts, prep-
arations thereof, matricaria recutita, preparations thereof,
zinc aspartate, sodim salicylate, sodium acetylsalicylate,
salicylic acid, methyl salicylate, carbasalate calcium and
bismuth subnitrate and aluminium salicylate, basic and
Acetylsalicylic acid DL-lysine should be inserted into
Annex II to Regulation (EEC) No 2377/90.

In order to allow for the completion of scientific studies,
methylprednisolone and acetylisovaleryltylosin should
be inserted into Annex III to Regulation (EEC) No 2377/
90.

An adequate period should be allowed before the entry
into force of this Regulation in order to allow Member
States to make any adjustment which may be necessary
to the authorisations to place the veterinary medicinal
products concerned on the market which have been
granted in accordance with Council Directive 81/
851/EEC (3), as last amended by Directive 93/40/EEC (4)
to take account of the provisions of this Regulation.

(10)

The measures provided for in this Regulation are in
accordance with the opinion of the Standing Committee
on Veterinary Medicinal Products,

HAS ADOPTED THE FOLLOWING REGULATION:

Article 1

Annexes I,
hereby amended as set out in the Annex hereto.

II and III of Regulation (EEC) No 2377/90 are

Article 2

This Regulation shall enter
into force on the third day
following its publication in the Official Journal of the European
Communities.

(5)

In the case of veterinary medicinal products intended for
lactating animals or honey bees,
use in laying birds,

It shall apply from the 60th day following its publication.

(1) OJ L 224, 18.8.1990, p. 1.
(2) OJ L 331, 23.12.1999, p. 49.

(3) OJ L 317, 6.11.1981, p. 1.
(4) OJ L 214, 24.8.1993, p. 31.

L 145/16

EN

Official Journal of the European Communities

20.6.2000

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 19 June 2000.

For the Commission

Erkki LIIKANEN

Member of the Commission

20.6.2000

EN

Official Journal of the European Communities

L 145/17

X
E
N
N
A

)
d
e
x
i
f

n
e
e
b

e
v
a
h

s
t
i

m

i
l

e
u
d
i
s
e
r

m
u
m
i
x
a
m

h
c
i
h
w

r
o
f

s
e
c
n
a
t
s
b
u
s

e
v
i
t
c
a

l

y
l
l
a
c
i
g
o
o
c
a
m
r
a
h
p

f
o

t
s
i
L
(

0
9
/
7
7
3
2

o
N

)

C
E
E
(

n
o
i
t
a
l
u
g
e
R

o
t

I

x
e
n
n
A

n

i

d
e
t
r
e
s
n

i

s
i

e
c
n
a
t
s
b
u
s

i

g
n
w
o

l
l

o
f

e
h
T

.

A

s
t
n
e
g
a

s
u
o
i
t
c
e
f
n
i
-
i
t
n
A

.

1

i

s
c
i
t
o
b
i
t
n
A

.

2
1

.

s
n
o
i
s
i
v
o
r
p

r
e
h
t
O

s
e
u
s
s
i
t

t
e
g
r
a
T

s
L
R
M

s
e
i
c
e
p
s

l
a
m
n
A

i

e
u
d
i
s
e
r

r
e
k
r
a
M

e
v
i
t
c
a

l

y
l
l
a
c
i
g
o
o
c
a
m
r
a
h
P

)
s
(
e
c
n
a
t
s
b
u
s

s
n

i
l
l
i
c
i
n
e
P

.

e
l
c
s
u
M

r
e
v
i
L

’

y
e
n
d
K

i

g
k
/
g
µ

g
k
/
g
µ

g
k
/
g
µ

5
2

5
2

5
2

e
n
i
c
r
o
P

n

i
l
l
i
c
i
n
e
p
l
y
h
t
e
m
y
x
o
n
e
h
P

n

i
l
l
i
c
i
n
e
p
l
y
h
t
e
m
y
x
o
n
e
h
P

‘

.

1
2
1

.

s
n
o
i
s
i
v
o
r
p

r
e
h
t
O

s
e
i
c
e
p
s

l
a
m
n
A

i

)
s
(
e
c
n
a
t
s
b
u
s

e
v
i
t
c
a

l

y
l
l
a
c
i
g
o
o
c
a
m
r
a
h
P

h
s
i
f

t
p
e
c
x
e

s
e
i
c
e
p
s

g
n
i
c
u
d
o
r
p

d
o
o
f

y
l
n
o

e
s
u

l
a
c
i
p
o
t

l
l

A

r
o
F

c
i
s
a
b

,
e
t
a
l
y
c
i
l
a
s

i

i

m
u
n
m
u
A

l

‘

)
s
t
i

m

i
l

e
u
d
i
s
e
r

m
u
m
i
x
a
m

o
t

t
c
e
j
b
u
s

t
o
n

s
e
c
n
a
t
s
b
u
s

f
o

t
s
i
L
(

0
9
/
7
7
3
2

o
N

)

C
E
E
(

n
o
i
t
a
l
u
g
e
R

o
t

I
I

x
e
n
n
A

n

i

d
e
t
r
e
s
n

i

e
r
a

s
e
c
n
a
t
s
b
u
s

i

g
n
w
o

l
l

o
f

e
h
T

.

B

s
d
n
u
o
p
m
o
c

c
i
n
a
g
r
O

.

2

y
l
n
o

e
s
u

y
r
a
m
m
a
m
a
r
t
n

i

r
o
F

e
n
i
v
o
B

e
t
a
r
t
i
n
b
u
s

h
t
u
m

s
i
B

s
e
i
c
e
p
s

g
n
i
c
u
d
o
r
p

d
o
o
f

l
l

A

e
t
a
t
r
a
p
s
a

m
u
i
c
l
a
C

y
l
n
o

e
s
u

l
a
c
i
p
o
t

r
o
F

h
s
i
f

t
p
e
c
x
e

s
e
i
c
e
p
s

g
n
i
c
u
d
o
r
p

d
o
o
f

l
l

A

y
l
n
o

e
s
u

l
a
c
i
p
o
t

r
o
F

h
s
i
f

t
p
e
c
x
e

s
e
i
c
e
p
s

g
n
i
c
u
d
o
r
p

d
o
o
f

l
l

A

’

y
l
n
o

e
s
u

l
a
c
i
p
o
t

r
o
F

h
s
i
f

t
p
e
c
x
e

s
e
i
c
e
p
s

g
n
i
c
u
d
o
r
p

d
o
o
f

l
l

A

s
e
i
c
e
p
s

g
n
i
c
u
d
o
r
p

d
o
o
f

l
l

A

e
t
a
l
y
c
i
l
a
s

l
y
h
t
e
M

d
i
c
a

c
i
l
y
c
i
l
a
S

e
t
a
l
y
c
i
l
a
s

i

m
u
d
o
S

e
t
a
t
r
a
p
s
a

c
n
Z

i

L 145/18

EN

Official Journal of the European Communities

20.6.2000

e
u
d
i
s
e
r

m
u
m
i
x
a
m

l
a
n
o
i
s
i
v
o
r
p

h
c
i
h
w

r
o
f

s
t
c
u
d
o
r
p

l
a
n
i
c
i
d
e
m
y
r
a
n
i
r
e
t
e
v

n

i

d
e
s
u

s
e
c
n
a
t
s
b
u
s

e
v
i
t
c
a

l

y
l
l
a
c
i
g
o
o
c
a
m
r
a
h
p

f
o

t
s
i
L
(

0
9
/
7
7
3
2

o
N

)

C
E
E
(

n
o
i
t
a
l
u
g
e
R

o
t

I
I
I

x
e
n
n
A
n

i

d
e
t
r
e
s
n

i

e
r
a

s
e
c
n
a
t
s
b
u
s

i

g
n
w
o

l
l

o
f

e
h
T

.

C

s
n
o
i
s
i
v
o
r
p

r
e
h
t
O

s
e
i
c
e
p
s

l
a
m
n
A

i

)
s
(
e
c
n
a
t
s
b
u
s

e
v
i
t
c
a

l

y
l
l
a
c
i
g
o
o
c
a
m
r
a
h
P

n
i
g
i
r
o

e
l
b
a
t
e
g
e
v

f
o

s
e
c
n
a
t
s
b
u
S

.

6

s
e
i
c
e
p
s

g
n
i
c
u
d
o
r
p

d
o
o
f

l
l

A

f
o
e
r
e
h
t

s
n
o
i
t
a
r
a
p
e
r
p

d
n
a

a
t
i
t
u
c
e
r

a
i
r
a
c
i
r
t
a
M

‘

’

s
e
i
c
e
p
s

g
n
i
c
u
d
o
r
p

d
o
o
f

l
l

A

f
o
e
r
e
h
t

s
n
o
i
t
a
r
a
p
e
r
p

d
n
a

s
t
c
a
r
t
x
e

d
e
s
i
d
r
a
d
n
a
t
s

,

x
i
d
a
r

i
e
h
R

s
t
n
e
g
a

s
u
o
i
t
c
e
f
n
i
-
i
t
n
A

.

1

)
d
e
x
i
f

n
e
e
b

e
v
a
h

s
t
i

m

i
l

i

s
c
i
t
o
b
i
t
n
A

.

2
1

.

s
n
o
i
s
i
v
o
r
p

r
e
h
t
O

s
e
u
s
s
i
t

t
e
g
r
a
T

s
L
R
M

s
e
i
c
e
p
s

l
a
m
n
A

i

e
u
d
i
s
e
r

r
e
k
r
a
M

e
v
i
t
c
a

l

y
l
l
a
c
i
g
o
o
c
a
m
r
a
h
P

)
s
(
e
c
n
a
t
s
b
u
s

s
e
d

i
l

o
r
c
a
M

.

.

2
2
1

.

n

i

e
s
u

r
o
f

t
o
N

.

’

1
0
0
2
7
1

.

.

n
o

e
r
i
p
x
e

s
L
R
M

l
a
n
o
i
s
i
v
o
r
P

e
l
c
s
u
M

g
k
/
g
µ

0
0
1

e
n
i
c
r
o
P

n
i
s
o
l
y
t
l
y
r
e
l
a
v
o
s
i
l
y
t
e
c
a

f
o

m
u
S

n
i
s
o
l
y
t
l
y
r
e
l
a
v
o
s
i
l
y
t
e
c
A

‘

t
a
f

d
n
a

n
i
k
S

g
k
/
g
µ

0
0
1

y
e
n
d
K

i

g
k
/
g
µ

0
0
1

r
e
v
i
L

g
k
/
g
µ

0
0
1

n
i
s
o
l
y
t
l
y
t
e
c
a
-
O
-
3

d
n
a

i

s
d
o
c
i
t
r
o
C

i

s
d
o
c
i
t
r
o
c
o
c
u
G

l

.

1
7

.

.

7

s
n
o
i
s
i
v
o
r
p

r
e
h
t
O

s
e
u
s
s
i
t

t
e
g
r
a
T

s
L
R
M

s
e
i
c
e
p
s

l
a
m
n
A

i

e
u
d
i
s
e
r

r
e
k
r
a
M

e
v
i
t
c
a

l

y
l
l
a
c
i
g
o
o
c
a
m
r
a
h
P

)
s
(
e
c
n
a
t
s
b
u
s

n
a
m
u
h

r
o
f

d
e
c
u
d
o
r
p

s
i

k
l
i

m
h
c
i
h
w
m
o
r
f

s
l
a
m
n
a

i

’

n
o
i
t
p
m
u
s
n
o
c

1
0
0
2
7
1

.

.

n
o

e
r
i
p
x
e

s
L
R
M

l
a
n
o
i
s
i
v
o
r
P

e
l
c
s
u
M

r
e
v
i
L

t
a
F

y
e
n
d
K

i

g
k
/
g
µ

g
k
/
g
µ

g
k
/
g
µ

g
k
/
g
µ

0
1

0
1

0
1

0
1

e
n
i
v
o
B

l

e
n
o
o
s
i
n
d
e
r
p
l
y
h
t
e
M

l

e
n
o
o
s
i
n
d
e
r
p
l
y
h
t
e
M

‘